Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Food allergy drug developer Alladapt raised $119M in new funding

By: via Business Journals
The funding comes as the Menlo Park company has begun a clinical trial and is building a manufacturing plant.
Related Stocks:
Harbor Disruptive Innovation ETF
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.